Total Payments
$379.83
2023 Payments
$16.38
Companies
6
Transactions
12
Medicare Patients
10,720
Medicare Billing
$644,536
Payment Breakdown by Category
Food & Beverage$379.83 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $379.83 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $118.73 | 3 | $0 (2018) |
| The Medicines Company | $108.30 | 2 | $0 (2017) |
| Allergan Inc. | $52.35 | 3 | $0 (2018) |
| Melinta Therapeutics, Inc. | $47.77 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $36.30 | 2 | $0 (2021) |
| Foundation Medicine, Inc. | $16.38 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $16.38 | 1 | Foundation Medicine, Inc. ($16.38) |
| 2021 | $22.87 | 1 | AstraZeneca Pharmaceuticals LP ($22.87) |
| 2018 | $131.23 | 4 | Merck Sharp & Dohme Corporation ($55.90) |
| 2017 | $209.35 | 6 | The Medicines Company ($108.30) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/28/2023 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID CDX | Food and Beverage | In-kind items and services | $16.38 | General |
| 06/21/2021 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Oncology | ||||||
| 09/25/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Oncology | ||||||
| 08/30/2018 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | Cash or cash equivalent | $47.77 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/25/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/11/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $55.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/09/2017 | The Medicines Company | ORBACTIV (Drug) | Food and Beverage | In-kind items and services | $55.49 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/06/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/29/2017 | The Medicines Company | ORBACTIV (Drug) | Food and Beverage | In-kind items and services | $52.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/28/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $39.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/16/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/11/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,879 | 4,560 | $613,221 | $174,495 |
| 2022 | 17 | 2,743 | 4,190 | $562,948 | $155,254 |
| 2021 | 18 | 2,510 | 3,688 | $503,817 | $155,172 |
| 2020 | 15 | 2,588 | 3,728 | $507,064 | $159,615 |
Total Patients
10,720
Total Services
16,166
Medicare Billing
$644,536
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,383 | 2,291 | $365,750 | $113,507 | 31.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 327 | 633 | $95,970 | $17,900 | 18.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 84 | 107 | $15,515 | $9,108 | 58.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 70 | 76 | $11,350 | $5,444 | 48.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 43 | 68 | $19,720 | $4,141 | 21.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 39 | 151 | $15,125 | $3,481 | 23.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 20 | 57 | $6,925 | $3,464 | 50.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 103 | 130 | $16,300 | $3,406 | 20.9% |
| 84165 | Protein measurement, serum | Facility | 2023 | 186 | 240 | $12,000 | $2,958 | 24.6% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2023 | 129 | 160 | $8,000 | $1,988 | 24.9% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 72 | 79 | $6,959 | $1,841 | 26.5% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 133 | 163 | $6,530 | $1,465 | 22.4% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Facility | 2023 | 11 | 42 | $6,300 | $1,322 | 21.0% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 99 | 132 | $10,712 | $1,072 | 10.0% |
| 86335 | Immunologic analysis technique on body fluid, other fluids with concentration | Facility | 2023 | 41 | 50 | $2,500 | $852.00 | 34.1% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2023 | 42 | 44 | $3,960 | $733.15 | 18.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 23 | 59 | $4,150 | $645.52 | 15.6% |
| 85097 | Bone marrow, smear interpretation | Facility | 2023 | 14 | 14 | $1,860 | $489.74 | 26.3% |
| 84166 | Protein measurement, body fluid | Facility | 2023 | 18 | 19 | $950.00 | $320.35 | 33.7% |
| 88363 | Examination of archival tissue for genetic analysis | Facility | 2023 | 18 | 20 | $1,000 | $269.28 | 26.9% |
| 88302 | Pathology examination of tissue using a microscope | Facility | 2023 | 13 | 13 | $1,105 | $52.50 | 4.8% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 11 | 12 | $540.00 | $34.10 | 6.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 1,273 | 1,941 | $309,540 | $94,279 | 30.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 383 | 813 | $123,340 | $26,519 | 21.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 134 | 160 | $20,375 | $5,040 | 24.7% |
About Dr. Naimin Wei, M.D
Dr. Naimin Wei, M.D is a Specialist/Technologist, Pathology healthcare provider based in Cumberland, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578674792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Naimin Wei, M.D has received a total of $379.83 in payments from pharmaceutical and medical device companies, with $16.38 received in 2023. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($379.83).
As a Medicare-enrolled provider, Wei has provided services to 10,720 Medicare beneficiaries, totaling 16,166 services with total Medicare billing of $644,536. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist/Technologist, Pathology
- Other Specialties Pathology
- Location Cumberland, MD
- Active Since 08/31/2006
- Last Updated 11/13/2007
- Taxonomy Code 246Q00000X
- Entity Type Individual
- NPI Number 1578674792
Products in Payments
- ZERBAXA (Drug) $118.73
- ORBACTIV (Drug) $108.30
- Orbactiv (Drug) $47.77
- AVYCAZ (Drug) $38.22
- TAGRISSO (Drug) $36.30
- DALVANCE (Drug) $14.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist/Technologist, Pathology Doctors in Cumberland
Dr. David Dusenbery, M.d, M.D
Specialist/Technologist, Pathology — Payments: $36.30
Specialist/Technologist, Pathology $36.30
Elmer Thompson, M.d, M.D
Specialist/Technologist, Pathology — Payments: $13.43
Specialist/Technologist, Pathology $13.43
Dr. Jonathan Walburn, M.d, M.D
Specialist/Technologist, Pathology
Specialist/Technologist, Pathology
Dr. Francisco Reyes, M.d, M.D
Specialist/Technologist, Pathology
Specialist/Technologist, Pathology